Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

1.

Pharmacological characterization of designer cathinones in vitro.

Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME.

Br J Pharmacol. 2013 Jan;168(2):458-70. doi: 10.1111/j.1476-5381.2012.02145.x.

PMID:
22897747
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.

Simmler LD, Rickli A, Hoener MC, Liechti ME.

Neuropharmacology. 2014 Apr;79:152-60. doi: 10.1016/j.neuropharm.2013.11.008. Epub 2013 Nov 22.

PMID:
24275046
[PubMed - in process]
3.

Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.

López-Arnau R, Martínez-Clemente J, Pubill D, Escubedo E, Camarasa J.

Br J Pharmacol. 2012 Sep;167(2):407-20. doi: 10.1111/j.1476-5381.2012.01998.x.

PMID:
22509960
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Behavioral pharmacology of designer cathinones: a review of the preclinical literature.

Gregg RA, Rawls SM.

Life Sci. 2014 Feb 27;97(1):27-30. doi: 10.1016/j.lfs.2013.10.033. Epub 2013 Nov 11. Review.

PMID:
24231450
[PubMed - indexed for MEDLINE]
5.

MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.

Verrico CD, Miller GM, Madras BK.

Psychopharmacology (Berl). 2007 Jan;189(4):489-503. Epub 2005 Oct 12.

PMID:
16220332
[PubMed - indexed for MEDLINE]
6.

Substituted methcathinones differ in transporter and receptor interactions.

Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A.

Biochem Pharmacol. 2013 Jun 15;85(12):1803-15. doi: 10.1016/j.bcp.2013.04.004. Epub 2013 Apr 10.

PMID:
23583454
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

German CL, Fleckenstein AE, Hanson GR.

Life Sci. 2014 Feb 27;97(1):2-8. doi: 10.1016/j.lfs.2013.07.023. Epub 2013 Aug 2. Review.

PMID:
23911668
[PubMed - indexed for MEDLINE]
8.

Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.

Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW.

Neuropsychopharmacology. 2013 Mar;38(4):552-62. doi: 10.1038/npp.2012.204. Epub 2012 Oct 17.

PMID:
23072836
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Designer psychostimulants: Pharmacology and differences.

Iversen L, White M, Treble R.

Neuropharmacology. 2014 Jan 20. pii: S0028-3908(14)00022-7. doi: 10.1016/j.neuropharm.2014.01.015. [Epub ahead of print] Review.

PMID:
24456744
[PubMed - as supplied by publisher]
10.

Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption.

Blum K, Foster Olive M, Wang KK, Febo M, Borsten J, Giordano J, Hauser M, Gold MS.

Med Hypotheses. 2013 Sep;81(3):450-5. doi: 10.1016/j.mehy.2013.06.007. Epub 2013 Jul 8.

PMID:
23845561
[PubMed - indexed for MEDLINE]
11.

Psychoactive "bath salts": not so soothing.

Baumann MH, Partilla JS, Lehner KR.

Eur J Pharmacol. 2013 Jan 5;698(1-3):1-5. doi: 10.1016/j.ejphar.2012.11.020. Epub 2012 Nov 23. Review.

PMID:
23178799
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The toxicology of bath salts: a review of synthetic cathinones.

Prosser JM, Nelson LS.

J Med Toxicol. 2012 Mar;8(1):33-42. doi: 10.1007/s13181-011-0193-z. Review.

PMID:
22108839
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.

Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF, Brandt SD, Rothman RB, Ruoho AE, Cozzi NV.

Neuropsychopharmacology. 2012 Apr;37(5):1192-203. doi: 10.1038/npp.2011.304. Epub 2011 Dec 14.

PMID:
22169943
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone.

den Hollander B, Rozov S, Linden AM, Uusi-Oukari M, Ojanperä I, Korpi ER.

Pharmacol Biochem Behav. 2013 Jan;103(3):501-9. doi: 10.1016/j.pbb.2012.10.006. Epub 2012 Oct 22.

PMID:
23099177
[PubMed - indexed for MEDLINE]
15.

Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.

Cameron KN, Kolanos R, Solis E Jr, Glennon RA, De Felice LJ.

Br J Pharmacol. 2013 Apr;168(7):1750-7. doi: 10.1111/bph.12061.

PMID:
23170765
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.

Glennon RA.

Adv Pharmacol. 2014;69:581-620. doi: 10.1016/B978-0-12-420118-7.00015-9.

PMID:
24484988
[PubMed - in process]
17.

Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs.

Cozzi NV, Brandt SD, Daley PF, Partilla JS, Rothman RB, Tulzer A, Sitte HH, Baumann MH.

Eur J Pharmacol. 2013 Jan 15;699(1-3):180-7. doi: 10.1016/j.ejphar.2012.11.008. Epub 2012 Nov 21.

PMID:
23178523
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology.

De Felice LJ, Glennon RA, Negus SS.

Life Sci. 2014 Feb 27;97(1):20-6. doi: 10.1016/j.lfs.2013.10.029. Epub 2013 Nov 11. Review.

PMID:
24231923
[PubMed - indexed for MEDLINE]
19.

Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats.

Bonano JS, Glennon RA, De Felice LJ, Banks ML, Negus SS.

Psychopharmacology (Berl). 2014 Jan;231(1):199-207. doi: 10.1007/s00213-013-3223-5. Epub 2013 Aug 15.

PMID:
23949206
[PubMed - indexed for MEDLINE]
20.

[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.

Johnson RA, Eshleman AJ, Meyers T, Neve KA, Janowsky A.

Synapse. 1998 Sep;30(1):97-106.

PMID:
9704886
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk